about
Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphataseAutocrine PDGFR signaling promotes mammary cancer metastasisAntiangiogenesis cocktails - stirred or shaken?Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitorPhase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancersProfile of nintedanib in the treatment of solid tumors: the evidence to dateStructural and functional properties of platelet-derived growth factor and stem cell factor receptorsCancer cell invasion is enhanced by applied mechanical stimulationHydrophobic Matching Controls the Tilt and Stability of the Dimeric Platelet-derived Growth Factor Receptor (PDGFR) Transmembrane SegmentCilia and developmental signalingBone Physiology, Biomaterial and the Effect of Mechanical/Physical Microenvironment on MSC Osteogenesis: A Tribute to Shu Chien's 80th BirthdayFunctions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targetingRole of platelet-derived growth factors in physiology and medicinePhase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.Bioinformatics and Drug Discovery.Sunitinib malate for the treatment of solid tumours: a review of current clinical data.Update on the cytogenetics and molecular genetics of chordomaLate treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse modelSynthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expressionCancer and the tumor microenvironment: a review of an essential relationship.Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expressionE7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasionILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progressionClinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic diseasePDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.Identification of unique expression signatures and therapeutic targets in esophageal squamous cell carcinoma.PDGFRβ signaling regulates mural cell plasticity and inhibits fat development.Cancer-stromal cell interaction and tumor angiogenesis in gastric cancerMalignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signalingTargeting the PDGF signaling pathway in the treatment of non-malignant diseases.Ubiquitination-dependent regulation of signaling receptors in cancer.Targeting the PDGF signaling pathway in tumor treatmentRole of Notch and its oncogenic signaling crosstalk in breast cancer.Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cellsThe role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressivenessCritical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases.Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats.
P2860
Q24308779-F5983FDC-9004-40F3-8AB7-034C2E776541Q24545375-392C354E-AF94-4E3C-9A01-E59E086565D0Q24548357-DD1B5E95-8D2F-4ACF-AA9D-61A532BC66B9Q24594930-597CABEF-15A6-42BE-93B4-BBBD78A9FBBBQ24644683-DA23CE74-C679-4109-9A24-E5DECA1D4A67Q26775134-7A788BC3-D4FF-4F3D-B736-1CD302DA6D18Q26829546-7E33926B-AFA3-4F99-9AE0-DF650D068D69Q27350422-EF5B589C-AC05-4EE4-A957-CDC4BD6134F9Q27679255-8B0F92C3-F599-4F25-8E00-D76545803F61Q28302606-F5A8CE49-4EEB-4848-A96D-B83B77522C4FQ28652480-188C49F3-2473-4156-A2E9-0B4620AE0591Q28755868-02E80F77-1ED2-401D-A687-390E8100BC5AQ29615222-2D817755-4554-4AF7-B661-EA7E3ECE88D1Q30361848-B60D1BA6-C81B-43CF-A6B2-804123CD6525Q30395256-268F73FC-128A-4022-AF22-0FFFE5BE0559Q31037756-1015A4AD-8EA4-4A44-90DD-3CC614C29894Q33273719-859FA3AF-90F0-4074-A2B5-02B4FD9B4304Q33574341-78E09768-7A8E-4E34-8D99-AECBC6962E72Q33762115-9E743AA2-F748-43CA-8BAF-836C09162002Q33802125-F412385F-56A4-4DD7-A24D-BF536F3E6774Q33806357-8FF53DEC-9ECF-48EE-96C8-2C4E230B7F26Q33843587-370079EE-0979-4D91-AAEF-77C7C15059EEQ33968953-1CA209E6-647A-46D6-992B-8182227FC7BDQ33977419-EB49129A-2B5F-4709-A503-C5B8D00DF399Q34091198-B7EE59D2-630A-468E-8F17-A5169CA5D325Q34140712-35CC4453-E3A1-4E2F-880D-0C0637BC8CFDQ34142332-5AFE6113-EA0B-4893-B26A-2732D5012CE8Q34191687-95E23EF4-613B-4A5C-A490-8C60D08C1ACBQ34268727-F2499721-1279-48A0-83FE-31D3741A730AQ34309316-1BC096AA-8D15-4B06-B6F7-D3A06368A974Q34352802-7B4CC6D3-3273-4C66-8ED1-C07F26B231B7Q34365210-2BCBE302-D1F5-4930-880E-08315C6F1B71Q34393461-993EF198-8641-4E5F-8F3A-F26932AC00E9Q34697373-D13BFF82-E081-48F3-BE1F-4643E104A2E0Q34751465-A7BB3F5E-671C-4220-B19C-5E77C403D20FQ34780162-08BFCBF7-DE50-49CF-94B9-2E54071A9317Q34885299-F7FEE308-6540-4A01-95C0-54420088013FQ34894883-C3BC70C4-4C22-45B9-BF0D-CE2411C3F610Q35161761-F6551BAD-9167-4BCE-AAD4-99599E38D2E0Q35191172-D4581988-4D1D-4F17-84F4-B40A97D3A55E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
PDGF receptors as cancer drug targets.
@ast
PDGF receptors as cancer drug targets.
@en
type
label
PDGF receptors as cancer drug targets.
@ast
PDGF receptors as cancer drug targets.
@en
prefLabel
PDGF receptors as cancer drug targets.
@ast
PDGF receptors as cancer drug targets.
@en
P2093
P1433
P1476
PDGF receptors as cancer drug targets.
@en
P2093
Arne Ostman
Carl-Henrik Heldin
Kristian Pietras
Kristofer Rubin
Tobias Sjöblom
P304
P356
10.1016/S1535-6108(03)00089-8
P577
2003-05-01T00:00:00Z